Hoth Therapeutics, Inc. (NASDAQ: HOTH)

Hoth Therapeutics, Inc. (NASDAQ: HOTH) is a forward-thinking clinical-stage biopharmaceutical company dedicated to developing next-generation therapeutics that address critical unmet patient needs. With a strong commitment to innovation, Hoth Therapeutics operates as a catalyst in early-stage pharmaceutical research and development, driving promising drugs from initial laboratory discoveries through to rigorous clinical testing.

Hoth Therapeutics employs a patient-centric approach, actively collaborating with leading scientists, clinicians, and key opinion leaders to identify and advance medications with the potential to create significant breakthroughs and expand treatment options. Hoth Therapeutics' diverse pipeline spans several therapeutic areas, including oncology, dermatology, neurology, and more, reflecting its broad commitment to improving patient outcomes.

Located at One Rockefeller Plaza, 10th FL, New York, NY 10020, US, Hoth Therapeutics is poised to make significant contributions to the healthcare landscape. We invite the management team at Hoth Therapeutics to enhance your company's presence by creating a customized and exclusive company showcase and product listing on our platform.